Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.
The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.
As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.
IC3 Annual Student Quest Report 2025: Students Prioritize Well-Being, Purpose, & Affordability Over Rankings
Canada's Winter Intake: A Strategic Gateway For Indian Students' Global Careers
'What’s The Point Of TCs?’ Commuter Calls Out First-Class Ticket Misuse On Mumbai Locals
Gold Below ₹1.5 Lakh, Silver Below ₹2.5 Lakh As CME Margin Hike Sparks Sharp Sell-Off
